Otsuka Holdings
4578.T
#799
Rank
โ‚น2.743 T
Marketcap
โ‚น5,195
Share price
-1.25%
Change (1 day)
14.91%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): โ‚น258.54

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น277.54. In 2024 the company made an earnings per share (EPS) of โ‚น364.20 an increase over its 2023 EPS that were of โ‚น143.44.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น258.54-29.01%
2024โ‚น364.20153.9%
2023โ‚น143.44-15.71%
2022โ‚น170.17-6.18%
2021โ‚น181.38-24.1%
2020โ‚น238.9822.95%
2019โ‚น194.3756.13%
2018โ‚น124.49-25.11%
2017โ‚น166.2425.99%
2016โ‚น131.95-6.37%
2015โ‚น140.94
2014N/A-100%
2013โ‚น212.3418.06%
2012โ‚น179.851.01%
2011โ‚น178.0529.07%
2010โ‚น137.95-94.47%
2009โ‚น2,494